Literature DB >> 21330096

A cost analysis of a hospital-based palliative care outreach program: implications for expanding public sector palliative care in South Africa.

Charles Hongoro1, Natalya Dinat.   

Abstract

CONTEXT: Increasing access to palliative care services in low- and middle-income countries is often perceived as unaffordable despite the growing need for such services because of the increasing burden of chronic diseases including HIV and AIDS.
OBJECTIVES: The aim of the study was to establish the costs and cost drivers for a hospital outreach palliative care service in a low-resource setting, and to elucidate possible consequential quality-of-life improvements and potential cost savings.
METHODS: The study used a cost accounting procedure to cost the hospital outreach services--using a step-down costing method to measure unit (average) costs. The African Palliative Care Association Palliative Outcome Score (APCA POS) was applied at five intervals to a cohort of 72 consecutive and consenting patients, enrolled in a two-month period.
RESULTS: The study found that of the 481 and 1902 patients registered for outreach and in-hospital visits, respectively, 4493 outreach hospital visits and 3412 in-hospital visits were done per year. The costs per hospital outreach visit and in-hospital visit were US$71 and US$80, respectively. The cost per outreach visit was 50% less than the average cost of a patient day equivalent for district hospitals of $142. Some of the POS of a subsample (n=72) showed statistically significant improvements.
CONCLUSION: Hospital outreach services have the potential to avert hospital admissions in generally overcrowded services in low-resource settings and may improve the quality of life of patients in their home environments.
Copyright © 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21330096     DOI: 10.1016/j.jpainsymman.2010.08.014

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

1.  Care of the patient with XDR-TB who has failed treatment.

Authors:  Karen Blake Jacobson; Matthew Tate; Francois Eksteen; Anthony Moll; Nesri Padayatchi; Gerald Friedland; Sheela Shenoi
Journal:  Lancet Respir Med       Date:  2015-04       Impact factor: 30.700

2.  A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa.

Authors:  Kristal Duncan; Edina Sinanovic
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

3.  Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya.

Authors:  Elisabeth L Vodicka; Michael H Chung; Marita R Zimmermann; Rose J Kosgei; Fan Lee; Nelly R Mugo; Timothy C Okech; Samah R Sakr; Andy Stergachis; Louis P Garrison; Joseph B Babigumira
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

4.  The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case.

Authors:  Gesine Meyer-Rath; Craig van Rensburg; Calvin Chiu; Rahma Leuner; Lise Jamieson; Steve Cohen
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

5.  Symptom prevalence and burden, and the risk of depression among patients with advanced cancer attending two South African oncology units.

Authors:  Lindsay Farrant; Richard Harding; David Anderson; Linda Greeff; Reshma Kassanjee; R Krause; Zainab Mohamed; Jeannette Parkes; Liz Gwyther
Journal:  Ecancermedicalscience       Date:  2022-01-27

6.  Prospective cohort study on the incidence and risk factors of emergency home visits among Japanese home care patients.

Authors:  Koki Kato; Masaya Tomita; Moe Kato; Takaaki Goto; Kyukei Nishizono
Journal:  J Gen Fam Med       Date:  2021-05-24

7.  Approaches to integrating palliative care into African health systems: a qualitative systematic review.

Authors:  Lara Court; Jill Olivier
Journal:  Health Policy Plan       Date:  2020-10-01       Impact factor: 3.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.